Search research articles
Contact Us
Filters
Showing results (241-250 of 264) with videos related to
Page
of 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Nature Genetics
|
June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancer
Elissa W P Wong, Merve Sahin, Rui Yang, et al.
Cancer Discovery
|
July 5, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
Amish J Patel, Sarah Warda, Jesper L V Maag, et al.
Nature Medicine
|
January 5, 2024
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
Michael C Heinrich, Robin L Jones, Suzanne George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Nature Genetics
|
January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
Naitao Wang, Mohini R Pachai, Dan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Science (New York, N.Y.)
|
May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Fanying Tang, Duo Xu, Shangqian Wang, et al.
Nature Medicine
|
May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Priscilla Merriam, James J Morrow, Emanuele Mazzola, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 264) with videos related to
Sort By:
Page
of 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Nature Genetics
|
June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancer
Elissa W P Wong, Merve Sahin, Rui Yang, et al.
Cancer Discovery
|
July 5, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
Amish J Patel, Sarah Warda, Jesper L V Maag, et al.
Nature Medicine
|
January 5, 2024
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
Michael C Heinrich, Robin L Jones, Suzanne George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Nature Genetics
|
January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
Naitao Wang, Mohini R Pachai, Dan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor
Ping Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Science (New York, N.Y.)
|
May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Fanying Tang, Duo Xu, Shangqian Wang, et al.
Nature Medicine
|
May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Priscilla Merriam, James J Morrow, Emanuele Mazzola, et al.
Page
of 27